Category:Start-Class pharmacology articles
Appearance
Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
FA | A | GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Redirect | Template | NA | ??? |
11 | 0 | 48 | 614 | 1,375 | 4,327 | 7,220 | 1 | 434 | 1,147 | 13 | 26 | 44 | 0 | 23 | 942 | 388 | 15 | 1 |
Pages in category "Start-Class pharmacology articles"
The following 200 pages are in this category, out of approximately 4,327 total. This list may not reflect recent changes.
(previous page) (next page)I
- Talk:Ibalizumab
- Talk:Ibandronic acid
- Talk:Iberogast
- Talk:Iboga-type alkaloid
- Talk:Ibogamine
- Talk:Ibopamine
- Talk:Ibrexafungerp
- Talk:Ibritumomab tiuxetan
- Talk:Ibudilast
- Talk:Ibuprofen/paracetamol
- Talk:Ibutamoren
- Talk:Ibutilide
- Talk:IC50
- Talk:Icatibant
- Talk:Iclaprim
- Talk:Icodextrin
- Talk:ICON PLC
- Talk:Icotinib
- Talk:Idarucizumab
- Talk:Idebenone
- Talk:Idecabtagene vicleucel
- Talk:Idelalisib
- Talk:IDFP
- Talk:Idiosyncratic drug reaction
- Talk:Idoxuridine
- Talk:Iduronidase
- Talk:Ifenprodil
- Talk:Ifosfamide
- Talk:Ignavine
- Talk:Iloperidone
- Talk:Iloprost
- Talk:ImClone Systems
- Talk:Imetelstat
- Talk:Imidacloprid/moxidectin
- Talk:Imidapril
- Talk:Imidazenil
- Talk:Imiglucerase
- Talk:Imipenem
- Talk:Imipenem/cilastatin/relebactam
- Talk:Imiquimod
- Talk:Imlifidase
- Talk:Immune-selective anti-inflammatory derivative
- Talk:Immunostimulant
- Talk:Immunotherapy
- Talk:Immunotoxin
- Talk:IMP-1088
- Talk:Inactivated vaccine
- Talk:Inavolisib
- Talk:Incarvillateine
- Talk:Incremental cost-effectiveness ratio
- Talk:Indacaterol
- Talk:Indacaterol/glycopyrronium bromide/mometasone
- Talk:Indapamide
- Talk:Indatraline
- Talk:Indatuximab ravtansine
- Talk:Indian Drugs and Pharmaceuticals
- Talk:Indian Pharmacopoeia Commission
- Talk:Indigo carmine
- Talk:Indiplon
- Talk:Indolamines
- Talk:Indolylpropylaminopentane
- Talk:Indonesian Food and Drug Authority
- Talk:Induction sealing
- Talk:Informed assent
- Talk:Ingenol mebutate
- Talk:Inhalable insulin
- Talk:Inhalation sedation
- Talk:Inhalational anesthetic
- Talk:Inhaler
- Talk:Iniparib
- Talk:INNA-051
- Talk:Inosine
- Talk:Inotersen
- Talk:Inotrope
- Talk:Inotuzumab ozogamicin
- Talk:Inovio COVID-19 vaccine
- Talk:Insufflation (medicine)
- Talk:Insulin degludec
- Talk:Insulin detemir
- Talk:Insulin glargine
- Talk:Insulin glargine/lixisenatide
- Talk:Insulin glulisine
- Talk:Insulin lispro
- Talk:Intas Pharmaceuticals
- Talk:Integrase inhibitor
- Talk:Interferon beta-1a
- Talk:Interferon beta-1b
- Talk:International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- Talk:International Federation of Pharmaceutical Manufacturers & Associations
- Talk:International nonproprietary name
- Talk:International Pharmaceutical Federation
- Talk:International Society for the History of Pharmacy
- Talk:Intradermal injection
- Talk:Intrathecal administration
- Talk:Invasomes
- Talk:Inverse agonist
- Talk:Inverse benefit law
- Talk:Investigational New Drug
- Talk:Investigator's brochure
- Talk:Iobenguane
- Talk:Iobitridol
- Talk:Iodine (125I) human albumin
- Talk:Iodine (medical use)
- Talk:Iodised salt
- Talk:Iodixanol
- Talk:Iodoform
- Talk:Iofetamine (123I)
- Talk:Ioflupane (123I)
- Talk:Iohexol
- Talk:Ionis Pharmaceuticals
- Talk:Iopentol
- Talk:Iotrolan
- Talk:Ioxaglic acid
- Talk:Ipilimumab
- Talk:Ipodate sodium
- Talk:Ipragliflozin
- Talk:Ipratropium bromide/salbutamol
- Talk:Iptacopan
- Talk:Irbesartan
- Talk:IRGD
- Talk:Irofulven
- Talk:Iron polymaltose
- Talk:Iron(II,III) oxide
- Talk:Iron(II) gluconate
- Talk:Ironomycin
- Talk:Irosustat
- Talk:Isatuximab
- Talk:Isavuconazonium
- Talk:Samira Islam
- Talk:Isobutyl nitrite
- Talk:Isobutyric acid
- Talk:Isobutyrylfentanyl
- Talk:Isocarboxazid
- Talk:Isocitric acid
- Talk:Isofentanyl
- Talk:Isoflurane
- Talk:Isoglutamine
- Talk:Isoleucine
- Talk:Isomyosamine
- Talk:Isoniazid
- Talk:Isoprenaline
- Talk:Isopropyl nitrite
- Talk:Isosorbide
- Talk:Isosorbide dinitrate
- Talk:Isovaleric acid
- Talk:ISPOR
- Talk:Isradipine
- Talk:Italian Medicines Agency
- Talk:Itameline
- Talk:ITH Pharma
- Talk:ITI-1549
- Talk:Itopride
- Talk:Ivosidenib
- Talk:IVX-411
- Talk:Ixazomib
- Talk:Ixekizumab
J
- Talk:David Jack (pharmacologist)
- Talk:Markku Jalkanen
- Talk:Hanneke Jansen
- Talk:Janssen Pharmaceuticals
- Talk:Janssen Vaccines
- Talk:Janus kinase inhibitor
- Talk:Jazz Pharmaceuticals
- Talk:JDTic
- Talk:Jelleine
- Talk:JHW-007
- Talk:Jiangsu Hengrui
- Talk:JJC8-016
- Talk:JJC8-088
- Talk:JJC8-091
- Talk:Albert Jodlbauer
- Talk:John Johnstone (mayor)
- Talk:Joint Commission of Pharmacy Practitioners
- Talk:Josamycin
- Talk:Journal of Food and Drug Analysis
- Talk:Journal of Pharmacology and Experimental Therapeutics
- Talk:JQ1
- Talk:Jun12682
- Talk:JUPITER trial
- Talk:JWH-007
- Talk:JWH-015
- Talk:JWH-019
- Talk:JWH-051
- Talk:JWH-073
- Talk:JWH-122
- Talk:JWH-176
- Talk:JWH-200
- Talk:JWH-203
- Talk:JWH-210